1315326-93-2

Upstream product

• 1315326-92-1 (2S,4R)-1-((S)-2-amino-3,3-dimethylbutanoyl)-N-((2S)-1-(cyclopropylsulfonyl-carbamoyl)-2-vinylcyclopropyl)-4-(2-(4-isopropoxyphenyl)furo[3,2-b]pyridine[3,2-d]pyrimidin-4-yloxy)pyrrolidine-2-carboxamide hydrochloride salt 
• 6160-65-2 1,1'-Thiocarbonyldiimidazole 
• 932-35-4 3-hydroxypyridine-2-carbonitrile 
• 1315326-84-1 2-[(2-cyanopyridin-3-yl)oxy]acetamide 
• 1315326-91-0 tert-butyl (2S)-1-((2S,4R)-2-((2S)-1-(cyclopropylsulfonyl-carbamoyl)-2-vinylcyclopropylcarbamoyl)-4-(2-(4-isopropoxyphenyl)furo[3,2-b]pyridine[3,2-d]pyrimidin-4-yloxy)pyrrolidin-1-yl)-3,3-dimethyl-1-oxobutan-2-ylcarbamate 
• 1315326-90-9 (2S,4R)-N-((2S)-1-(cyclopropylsulfonylcarbamoyl)-2-vinylcyclopropyl)-4-(2-(4-isopropoxyphenyl)furo[3,2-b]pyridin[3,2-d]pyrimidin-4-yloxy)pyrrolidine-2-carboxamide hydrochloride 
• 1315326-89-6 (2S,4R)-tert-butyl 2-((2S)-1-(cyclopropyl-sulfonylcarbamoyl)-2-vinylcyclopropylcarbamoyl)-4-(2-(4-isopropoxyphenyl)furo[3,2-b]pyridin[3,2-d]pyrimidin-4-yloxy)pyrrolidine-1-carboxylate 
• 1315326-88-5 (2S,4R)-1-(tert-butoxycarbonyl)-4-(2-(4-isopropoxyphenyl)furo[3,2-b]pyridine[3,2-d]pyrimidin-4-yloxy)pyrrolidine-2-carboxylic acid 
• 1315326-86-3 2-(4-isopropoxy-phenyl)furo[3,2-b]pyridin[3,2-d]pyrimidin-4(3H)-one 
• 1315326-85-2 3-(4-isopropoxybenzamido)furo[3,2-b]pyridine-2-carboxamide 
• 917504-84-8 3-aminofuro[3,2-b]pyridine-2-carboxamide 

Downstream Products

• 1315326-94-3 2-((2S)-1-((2S,4R)-2-((2S)-1-(cyclopropylsulfonyl-carbamoyl)-2-vinyl-cyclopropylcarbamoyl)-4-(2-(4-isopropoxyphenyl)furo[3,2-b]pyridine[3,2-d]pyrimidin-4-yloxy)pyrrolidin-1-yl)-3,3-dimethyl-1-oxobutan-2-ylamino)thiazole-4-carboxylic acid 
• 1315325-29-1 methyl 2-((2S)-1-((2S,4R)-2-((2S)-1-(cyclopropylsulfonylcarbamoyl)-2-vinylcyclopropylcarbamoyl)-4-(2-(4-isopropoxyphenyl)furo[3,2-b]pyridine[3,2-d]pyrimidin-4-yloxy)-pyrrolidin-1-yl)-3,3-dimethyl-1-oxobutan-2-ylamino)thiazole-4-carboxylate 

Relevant academic research and scientific papers

HCV PROTEASE INHIBITORS

This invention relates to compounds of Formula (I), (II), or (III) shown in the specification. These compounds can be used to treat hepatitis C virus infection.